PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022
Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy
Diabetes: AdipoPharma’s first-in-class candidate – PATAS – shows improvement in whole-body insulin resistance and associated comorbidities in vivo
Naobios delivers FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
Endo Tools Therapeutics receives positive opinion from French High Authority for Health on Forfait Innovation scheme to treat patients with diabetes
Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in-class antibiotic NOSO-502
Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty
Carthera’s SonoCloud technology demonstrates safety and therapeutic potential in clinical trial on patients living with Alzheimer’s Disease
